Translating pharmacogenomic sequencing data into drug response predictions—How to interpret variants of unknown significance
British Journal of Clinical Pharmacology · 2025-02 · 91 (2) · 252-263
DOI: 10.1111/bcp.15915 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 16.10.2023. Verfasst von Roman Tremmel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. Hauptthemen laut MEDLINE: Pharmacogenetics, Precision Medicine, Pharmacogenomic Variants. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Robert Bosch Stiftung, Deutsche Forschungsgemeinschaft, German Cancer Research Center.
Abstract (Originalsprache)
The rapid development of sequencing technologies during the past 20 years has provided a variety of methods and tools to interrogate human genomic variations at the population level. Pharmacogenes are well known to be highly polymorphic and a plethora of pharmacogenomic variants has been identified in population sequencing data. However, so far only a small number of these variants have been functionally characterized regarding their impact on drug efficacy and toxicity and the significance of the vast majority remains unknown. It is therefore of high importance to develop tools and frameworks to accurately infer the effects of pharmacogenomic variants and, eventually, aggregate the effect of individual variations into personalized drug response predictions. To address this challenge, we here first describe the technological advances, including sequencing methods and accompanying bioinformatic processing pipelines that have enabled reliable variant identification. Subsequently, we highlight advances in computational algorithms for pharmacogenomic variant interpretation and discuss the added value of emerging strategies, such as machine learning and the integrative use of omics techniques that have the potential to further contribute to the refinement of personalized pharmacological response predictions. Lastly, we provide an overview of experimental and clinical approaches to validate in silico predictions. We conclude that the iterative feedback between computational predictions and experimental validations is likely to rapidly improve the accuracy of pharmacogenomic prediction models, which might soon allow for an incorporation of the entire pharmacogenetic profile into personalized response predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
- University of Tübingen, Tübingen, Germany.
- Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Helmholtz Information and Data Science School for Health, Karlsruhe/Heidelberg, Germany.
- Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Volker M Lauschke
Förderung
- Robert Bosch Stiftung
- Deutsche Forschungsgemeinschaft
- German Cancer Research Center
- Robert Bosch Center for Tumor Diseases
- Deutsches Krebsforschungszentrum
Zitieren
APA
Tremmel, R., Pirmann, S., Zhou, Y., & Lauschke, V. M. (2025). Translating pharmacogenomic sequencing data into drug response predictions—How to interpret variants of unknown significance. British Journal of Clinical Pharmacology, 91(2), 252-263. https://doi.org/10.1111/bcp.15915
Vancouver
Tremmel R, Pirmann S, Zhou Y, Lauschke VM. Translating pharmacogenomic sequencing data into drug response predictions—How to interpret variants of unknown significance. British Journal of Clinical Pharmacology. 2025;91(2):252-263. doi:10.1111/bcp.15915
BibTeX
@article{Tremmel2025,
author = {Tremmel, Roman and Pirmann, Sebastian and Zhou, Yitian and Lauschke, Volker M},
title = {Translating pharmacogenomic sequencing data into drug response predictions—How to interpret variants of unknown significance},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {2},
pages = {252--263},
doi = {10.1111/bcp.15915}
}
EUVIMED